EFS of HCL patients treated with cladribine according to prognostic parameters. (A) EFS in UM-HCL versus M-HCL. (B) EFS in HCL with large splenomegaly versus HCL without large splenomegaly. (C) EFS in HCL with leukocytosis versus HCL without leukocytosis.